RETA
Reata Pharmaceuticals, Inc. Class A Common Stock
RETA
RETA
Delisted
RETA was delisted on the 25th of September, 2023.
93 hedge funds and large institutions have $427M invested in Reata Pharmaceuticals, Inc. Class A Common Stock in 2018 Q2 according to their latest regulatory filings, with 20 funds opening new positions, 40 increasing their positions, 16 reducing their positions, and 13 closing their positions.
New
Increased
Maintained
Reduced
Closed
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more call options, than puts
Call options by funds: $ | Put options by funds: $
more capital invested
Capital invested by funds: $ → $
more first-time investments, than exits
New positions opened: | Existing positions closed:
8% more funds holding
Funds holding: 86 → 93 (+7)
0% more funds holding in top 10
Funds holding in top 10: 3 → 3 (0)
Holders
93
Holding in Top 10
3
Calls
$2.05M
Puts
$1.02M
Top Buyers
| 1 | +$13.1M | |
| 2 | +$10.9M | |
| 3 | +$7.68M | |
| 4 |
Point72 Asset Management
Stamford,
Connecticut
|
+$6.96M |
| 5 |
State Street
Boston,
Massachusetts
|
+$4.57M |
Top Sellers
| 1 | -$7.51M | |
| 2 | -$5.63M | |
| 3 | -$3.59M | |
| 4 |
LCM
Laurion Capital Management
New York
|
-$3.31M |
| 5 |
Alyeska Investment Group
Chicago,
Illinois
|
-$3.12M |